Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
NCT00996827 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2015-06-18
Summary
This project seeks to understand differences in the serum vitamin D levels and immune status in cutaneous malignant melanoma patients with different UV exposure histories in New Mexico.
Conditions
Sponsors & Collaborators
-
New Mexico Cancer Research Alliance
lead OTHER
Principal Investigators
-
Montasur Shaheen, MD · University of New Mexico
-
Marianne Berwick, PhD · University of New Mexico Cancer Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma
NCT00897546 ·Status: COMPLETED
-
Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma
NCT00849407 ·Status: UNKNOWN
-
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
NCT00937781 ·Status: COMPLETED
-
Molecular Epidemiology of Cutaneous Malignant Melanoma
NCT00341991 ·Status: COMPLETED
-
A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
NCT00633516 ·Status: COMPLETED
-
Mohs and Immunofluorescence for Malignant Melanoma In Situ
NCT02306512 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer
NCT05027009 ·Status: COMPLETED ·Phase: NA
-
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
NCT06154668 ·Status: RECRUITING
-
A Novel Treatment for Metastatic Melanoma
NCT00758797 ·Status: TERMINATED ·Phase: PHASE1
-
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
NCT01886235 ·Status: COMPLETED ·Phase: NA
-
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
NCT03028948 ·Status: COMPLETED ·Phase: NA
-
Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
NCT00416988 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
NCT01167998 ·Status: UNKNOWN
-
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
NCT03370861 ·Status: TERMINATED
-
Targeted Intervention for Melanoma Prevention
NCT00394134 ·Status: COMPLETED ·Phase: NA
-
Nuclear and Near-Infrared (NIR) Imaging in Melanoma
NCT01295931 ·Status: COMPLETED ·Phase: PHASE1
-
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
NCT01489423 ·Status: COMPLETED
-
Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy
NCT00897520 ·Status: COMPLETED
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma
NCT04017897 ·Status: UNKNOWN ·Phase: PHASE2
-
A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
NCT04099446 ·Status: WITHDRAWN
-
Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin
NCT00875381 ·Status: COMPLETED
-
Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics
NCT03643289 ·Status: UNKNOWN
-
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
NCT02828202 ·Status: RECRUITING